Company intelligence / Profile preview

Longevitan

Boston, Massachusetts, United Statesinstagram.com ↗

Ownership: Private
Development stage: Commercial

Overview

Longevitan’s products have undergone internal research and some clinical studies to validate efficacy for anti-aging benefits such as improved skin appearance, sleep quality, cognitive performance, immune function, muscle recovery, metabolic health, and more. However, these are not formal pharmaceutical clinical trial results but rather consumer-facing supplement outcomes.

Therapeutic areas: OtherDermatologyImmunologyNeurology
Modalities: Small moleculeNutraceutical
Industry: Food & Nutrition

Drug pipeline

2 assets

EPIGENO RECHARGE+ Gen 2.0

Commercial

Indications: Aging, Longevity

1 more asset in the full pipeline.

Request access →

Partnerships

Boston Innovation and Investment Group LLC

Beyond the preview

Go deeper on Longevitan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Longevitan.

Explore the full profile